Vensica Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $11M

  • Investors
  • 10

Vensica General Information

Description

Developer of an ultrasound-based drug delivery system designed to treat overactive bladder (OAB). The company's system leverages the known properties of ultrasound and is needle-free and the drug will be instilled in a quick, pain-free procedure after the delivery of ultrasound to the urinary bladder to improve the treatment and reduce recurrence rates, enabling medical professionals to safely and effectively deliver therapy to patients suffering from urinary overactive bladder.

Contact Information

Website
www.vensica.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • HaGavish Street 4
  • Netanya 4250706
  • Israel
+972
Primary Industry
Drug Delivery
Other Industries
Therapeutic Devices
Corporate Office
  • HaGavish Street 4
  • Netanya 4250706
  • Israel
+972

Vensica Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vensica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 28-Oct-2024 $11M Completed Clinical Trials - General
4. Later Stage VC 07-Feb-2022 Completed Clinical Trials - General
3. Corporate 02-Oct-2017 Completed Clinical Trials - General
2. Angel (individual) 19-Jul-2016 $500K $500K Completed Clinical Trials - General
1. Accelerator/Incubator Completed Startup
To view Vensica’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Vensica Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an ultrasound-based drug delivery system designed to treat overactive bladder (OAB). The company's system l
Drug Delivery
Netanya, Israel
10 As of 2024

Paris, France
 

Milan, Italy
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vensica Competitors (15)

One of Vensica’s 15 competitors is HighLife, a Venture Capital-Backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HighLife Venture Capital-Backed Paris, France
InnovHeart Venture Capital-Backed Milan, Italy
Valcare Venture Capital-Backed Herzliya, Israel
Kardium Venture Capital-Backed Burnaby, Canada
Urogen Pharma Formerly VC-backed Princeton, NJ
You’re viewing 5 of 15 competitors. Get the full list »

Vensica Patents

  • 17

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Vensica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210052873-A1 System and method for ultrasonic bladder therapeutic agent delivery Active 01-Apr-2018
US-11529506-B2 System and method for ultrasonic bladder therapeutic agent delivery Active 01-Apr-2018
US-20230097230-A1 System and method for ultrasonic bladder therapeutic agent delivery Pending 01-Apr-2018
EP-3773262-A1 System and method for ultrasonic bladder therapeutic agent delivery Pending 01-Apr-2018
EP-3773262-A4 System and method for ultrasonic bladder therapeutic agent delivery Pending 01-Apr-2018 A61M37/0092
To view Vensica’s complete patent history, request access »

Vensica Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vensica Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Agronetto Corporation Minority
Consensus Business Group Asset Manager Minority
Israel Biotech Fund Venture Capital Minority
Merz Pharma Corporation Minority
Cogentix Medical PE-Backed Company Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Vensica FAQs

  • When was Vensica founded?

    Vensica was founded in 2014.

  • Where is Vensica headquartered?

    Vensica is headquartered in Netanya, Israel.

  • What is the size of Vensica?

    Vensica has 10 total employees.

  • What industry is Vensica in?

    Vensica’s primary industry is Drug Delivery.

  • Is Vensica a private or public company?

    Vensica is a Private company.

  • What is Vensica’s current revenue?

    The current revenue for Vensica is .

  • How much funding has Vensica raised over time?

    Vensica has raised $32.5M.

  • Who are Vensica’s investors?

    Agronetto, Consensus Business Group, Israel Biotech Fund, Merz Pharma, and Cogentix Medical are 5 of 10 investors who have invested in Vensica.

  • Who are Vensica’s competitors?

    HighLife, InnovHeart, Valcare, Kardium, and Urogen Pharma are some of the 15 competitors of Vensica.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »